Integral Derivatives’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-21,800
Closed -$1.76M 874
2017
Q4
$1.76M Hold
21,800
0.03% 327
2017
Q3
$1.7M Buy
21,800
+200
+0.9% +$16.6K 0.03% 354
2017
Q2
$1.92M Sell
21,600
-3,100
-13% -$261K 0.04% 314
2017
Q1
$1.99M Sell
24,700
-31,800
-56% -$2.48M 0.04% 312
2016
Q4
$4.02M Buy
56,500
+29,600
+110% +$2.33M 0.07% 175
2016
Q3
$2.32M Buy
26,900
+13,300
+98% +$1.16M 0.05% 234
2016
Q2
$1.18M Buy
13,600
+9,300
+216% +$752K 0.03% 368
2016
Q1
$322K Sell
4,300
-1,600
-27% -$121K 0.01% 623
2015
Q4
$454K Sell
5,900
-5,800
-50% -$437K 0.01% 676
2015
Q3
$783K Buy
+11,700
New +$862K 0.02% 573
2015
Q1
Sell
-10,000
Closed -$722K 1283
2014
Q4
$722K Buy
10,000
+2,500
+33% +$174K 0.01% 792
2014
Q3
$465K Buy
+7,500
New +$477K 0.01% 999
2014
Q1
Sell
-10,000
Closed -$574K 1490
2013
Q4
$574K Buy
+10,000
New +$567K 0.01% 994

Other funds holding MDT

Integral Derivatives's MDT Position: Q4 2017 in Review

Integral Derivatives sold out of Medtronic (MDT) in Q4 2017, closing a stake of 6,616 shares — an estimated $530K sold.

Integral Derivatives first reported a position in MDT in Q3 2014 and held it in 8 quarters. The position peaked at $1.97M in Q4 2016. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Integral Derivatives reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 6,616 Medtronic shares in Q4 2017, an estimated $530K.
  • Integral Derivatives first reported a position in Medtronic in Q3 2014 and held it in 8 quarters.
  • Integral Derivatives's Medtronic position peaked at $1.97M in Q4 2016.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.